- Home
- NVMI vs RGEN Comparison
NVMI vs RGEN Comparison
Compare NVMI & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVMI
- RGEN
- Stock Information
- Founded
- NVMI 1993
- RGEN 1981
- Country
- NVMI Israel
- RGEN United States
- Employees
- NVMI N/A
- RGEN N/A
- Industry
- NVMI Electronic Components
- RGEN Medical/Dental Instruments
- Sector
- NVMI Technology
- RGEN Health Care
- Exchange
- NVMI Nasdaq
- RGEN Nasdaq
- Market Cap
- NVMI 6.9B
- RGEN 6.6B
- IPO Year
- NVMI 2000
- RGEN N/A
- Fundamental
- Price
- NVMI $254.36
- RGEN $124.35
- Analyst Decision
- NVMI Strong Buy
- RGEN Buy
- Analyst Count
- NVMI 5
- RGEN 9
- Target Price
- NVMI $282.50
- RGEN $167.38
- AVG Volume (30 Days)
- NVMI 268.8K
- RGEN 1.0M
- Earning Date
- NVMI 08-07-2025
- RGEN 07-29-2025
- Dividend Yield
- NVMI N/A
- RGEN N/A
- EPS Growth
- NVMI 53.35
- RGEN N/A
- EPS
- NVMI 7.36
- RGEN N/A
- Revenue
- NVMI $807,085,000.00
- RGEN $673,956,000.00
- Revenue This Year
- NVMI $30.96
- RGEN $14.14
- Revenue Next Year
- NVMI $7.00
- RGEN $14.32
- P/E Ratio
- NVMI $34.54
- RGEN N/A
- Revenue Growth
- NVMI 43.69
- RGEN 8.73
- 52 Week Low
- NVMI $154.00
- RGEN $102.97
- 52 Week High
- NVMI $291.99
- RGEN $182.52
- Technical
- Relative Strength Index (RSI)
- NVMI 42.22
- RGEN 54.96
- Support Level
- NVMI $265.82
- RGEN $111.15
- Resistance Level
- NVMI $278.19
- RGEN $127.57
- Average True Range (ATR)
- NVMI 10.51
- RGEN 4.80
- MACD
- NVMI -1.49
- RGEN 1.31
- Stochastic Oscillator
- NVMI 17.44
- RGEN 63.23
About NVMI Nova Ltd.
Nova Ltd is a semiconductor equipment manufacturer. The company provides metrology solutions for process control used in semiconductor manufacturing. The company offers in-line optical and x-ray stand-alone metrology systems, as well as integrated optical metrology systems. The product range consists of Nova 2040, Nova 3090Next, Nova i500 and i500 Plus, Nova T500, Nova T600, Nova V2600, HelioSense 100, Nova Hybrid Metrology solution, NovaMars. The company generates the majority of its revenue from China. Geographically the company has its business spread across the region of Taiwan, Korea, China, the United States, and Europe.
About RGEN Repligen Corporation
Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.